Skip to Main Content

Author Details

Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
2006
204
70
PMIDPaper TitleJournal TitlePublished Year
36564591Multiscale reorganization of the genome following DNA damage facilitates chromosome translocations via nuclear actin polymerization.Nat Struct Mol Biol2023
36821090Correction: The UVSSA complex alleviates MYC-driven transcription stress.J Cell Biol2023
36824731Genomic landscape of virus-associated cancers.medRxiv2023
33417699Dose-response modeling in high-throughput cancer drug screenings: an end-to-end approach.Biostatistics2022
35412614Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.Mol Cancer Res2022
35443168Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.Cell Rep2022
35558160Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.Oncoimmunology2022
35046097Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia.Cancer Discov2022
35149861Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.Nat Cancer2022
34930825SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes.Proc Natl Acad Sci U S A2022
32511304Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2.bioRxiv2021
33789982PDK1 Is Required for Maintenance of CD4<sup>+</sup> Foxp3<sup>+</sup> Regulatory T Cell Function.J Immunol2021
33928261<i>FYN-TRAF3IP2</i> induces NF-κB signaling-driven peripheral T cell lymphoma.Nat Cancer2021
33558758Comprehensive characterization of protein-protein interactions perturbed by disease mutations.Nat Genet2021
33585889Global Patterns of Recombination across Human Viruses.Mol Biol Evol2021
33500226Computing the Role of Alternative Splicing in Cancer.Trends Cancer2021
33930309Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.Cancer Cell2021
33606978Functional interrogation of DNA damage response variants with base editing screens.Cell2021
35121903ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.Nat Cancer2021
34381221A persistent look at how tumours evade therapy.Nature2021
34433651TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas.Clin Cancer Res2021
34458856Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.Nat Cancer2021
34131139iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4.Nat Commun2021
34129825Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.Cancer Cell2021
34321280A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors.Clin Cancer Res2021
34011400Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.Genome Med2021
34362430Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2.Genome Med2021
34050029Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.Proc Natl Acad Sci U S A2021
33404608The UVSSA complex alleviates MYC-driven transcription stress.J Cell Biol2021
33031100Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.J Clin Invest2021
33140187High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.Cancer Immunol Immunother2021
31173059arcasHLA: high-resolution HLA typing from RNAseq.Bioinformatics2020
35356801Double Empirical Bayes Testing.Int Stat Rev2020
33796864Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.Nat Cancer2020
34085047A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.Nat Cancer2020
31948941Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.Cancer Res2020
33225311Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.Blood Cancer Discov2020
33077955Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.Nat Med2020
33205104A Random Matrix Theory Approach to Denoise Single-Cell Data.Patterns (N Y)2020
33149237Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.Exp Mol Med2020
32915138A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors.Elife2020
32732999Identification of relevant genetic alterations in cancer using topological data analysis.Nat Commun2020
32989150CtIP-mediated DNA resection is dispensable for IgH class switch recombination by alternative end-joining.Proc Natl Acad Sci U S A2020
32753598MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.Nat Commun2020
32188705Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.Cancer Discov2020
32415751Active surveillance documents rates of clinical care seeking due to respiratory illness.Influenza Other Respir Viruses2020
32332164Pan-cancer analysis identifies mutations in <i>SUGP1</i> that recapitulate mutant SF3B1 splicing dysregulation.Proc Natl Acad Sci U S A2020
32560455A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries.Cancers (Basel)2020
32430477CD8<sup>+</sup> T-cell-Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas.Clin Cancer Res2020
32124312HLA Typing from RNA Sequencing and Applications to Cancer.Methods Mol Biol2020
  • 1 - 50 of 204

Recommended Authors

Daniele Ramazzotti
University of Milano-Bicocca
Career Start Year 2015
Number of shared co-authors 0
Marc Dabad
Universitat de Barcelona (UB)
Career Start Year 2013
Number of shared co-authors 4
Marta Gut
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 3
Chandra Sekhar Pedamallu
Broad Institute
Career Start Year 2009
Number of shared co-authors 16
Hannah Carter
University of California San Diego
Career Start Year 2008
Number of shared co-authors 3
Moritz Gerstung
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 2
Fabio Zanini
Stanford University
Career Start Year 2006
Number of shared co-authors 0
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 5
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 7
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 2
Kristen K Dang
Benaroya Research Institute at Virginia Mason
Career Start Year 2006
Number of shared co-authors 4
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 28
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Career Start Year 2004
Number of shared co-authors 14
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 30
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 9
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Laura Riva
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 24
Niko Beerenwinkel
ETH Zurich
Career Start Year 2002
Number of shared co-authors 1
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 7
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 42
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 6
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 2
Vineet Bafna
University of California San Diego
Career Start Year 1998
Number of shared co-authors 2
Robert A Holt
BC Cancer Research Institute
Career Start Year 1996
Number of shared co-authors 27
Patrick Gendron
University of Montreal
Career Start Year 1992
Number of shared co-authors 0
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 7
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 23
Vincent Ferretti
Ontario Institute for Cancer Research
Career Start Year 1986
Number of shared co-authors 4
Richard H Scheuermann
J. Craig Venter Institute
Career Start Year 1983
Number of shared co-authors 2

Collaborators

Jiguang Wang
The Hong Kong University of Science and Technology
Co-authored papers 27
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 19
Robin Fo??
Sapienza University.
Co-authored papers 16
Francesco Abate
Columbia University
Co-authored papers 16
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 16
Arnold J Levine
Simons Center for Systems Biology, Institute for Advanced Study
Co-authored papers 14
Riccardo Dalla-Favera
Institute for Cancer Genetics, Columbia University
Co-authored papers 14
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 13
Andrew X Chen
Columbia University
Co-authored papers 11
Sakellarios Zairis
Columbia University
Co-authored papers 10
Timothy Chu
University of California Riverside
Co-authored papers 9
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 9
Uttiya Basu
Columbia University Medical Center
Co-authored papers 8
Adam M Sonabend
Northwestern University
Co-authored papers 8
Erik Ladewig
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Oliver Elliott
Columbia University
Co-authored papers 7
Pablo G Camara
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 7
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 6
Craig Horbinski
Co-authored papers 6
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Jason K Sa
Korea University, College of Medicine
Co-authored papers 6
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Daniel J Brat
Co-authored papers 6
Mykola Bordyuh
Columbia University
Co-authored papers 6
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 5
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers 5
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers 5
Benjamin D Greenbaum
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 5
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Co-authored papers 5
Release 1.2